These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 29790787)
1. Colorectal Liver Metastases: A Pathologist's Guide to Creating an Informative Report and Improving Patient Care. Moreno Prats M; Sasatomi E; Stevenson HL Arch Pathol Lab Med; 2019 Feb; 143(2):251-257. PubMed ID: 29790787 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis. Stevenson HL; Prats MM; Sasatomi E BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766 [TBL] [Abstract][Full Text] [Related]
3. Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol. Fonseca GM; Herman P; Faraj SF; Kruger JAP; Coelho FF; Jeismann VB; Cecconello I; Alves VAF; Pawlik TM; de Mello ES Histopathology; 2018 Feb; 72(3):377-390. PubMed ID: 28858385 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of postoperative oxaliplatin- or irinotecan-based chemotherapy after curative resection of synchronous liver metastases from colorectal cancer. Hsu HC; Chou WC; Shen WC; Wu CE; Chen JS; Liau CT; Lin YC; Yang TS Anticancer Res; 2013 Aug; 33(8):3317-25. PubMed ID: 23898098 [TBL] [Abstract][Full Text] [Related]
5. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973). Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence. Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183 [TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review. Richardson AJ; Laurence JM; Lam VW J Vasc Interv Radiol; 2013 Aug; 24(8):1209-17. PubMed ID: 23885916 [TBL] [Abstract][Full Text] [Related]
8. Severe liver dysfunction and safe use of 5-fluorouracil leucovorin and oxaliplatin in one patient with metastatic colorectal carcinoma. Tural D; Akar E; Öztürk MA; Yıldız Ö; Turna H; Serdengeçti S J Cancer Res Ther; 2014; 10(3):745-8. PubMed ID: 25313774 [TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145 [TBL] [Abstract][Full Text] [Related]
10. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients. Komori H; Beppu T; Baba Y; Horino K; Imsung C; Masuda T; Hayashi H; Okabe H; Ootao R; Watanabe M; Takamori H; Iyama K; Baba H Int J Clin Oncol; 2010 Jun; 15(3):263-70. PubMed ID: 20238233 [TBL] [Abstract][Full Text] [Related]
15. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Benoist S; Nordlinger B Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377 [TBL] [Abstract][Full Text] [Related]
16. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C. Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089 [TBL] [Abstract][Full Text] [Related]
17. First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD). Carrato A; Abad A; Massuti B; Grávalos C; Escudero P; Longo-Muñoz F; Manzano JL; Gómez A; Safont MJ; Gallego J; García-Paredes B; Pericay C; Dueñas R; Rivera F; Losa F; Valladares-Ayerbes M; González E; Aranda E; Eur J Cancer; 2017 Aug; 81():191-202. PubMed ID: 28633089 [TBL] [Abstract][Full Text] [Related]
18. FOLFOX enables high resectability and excellent prognosis for initially unresectable colorectal liver metastases. Beppu T; Hayashi N; Masuda T; Komori H; Horino K; Hayashi H; Okabe H; Baba Y; Kinoshita K; Akira C; Watanebe M; Takamori H; Baba H Anticancer Res; 2010 Mar; 30(3):1015-20. PubMed ID: 20393029 [TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin-induced liver injury mimicking metastatic tumor on images: a case report. Uchino K; Fujisawa M; Watanabe T; Endo Y; Nobuhisa T; Matsumoto Y; Kai K; Sato S; Notohara K; Matsukawa A Jpn J Clin Oncol; 2013 Oct; 43(10):1034-8. PubMed ID: 23958518 [TBL] [Abstract][Full Text] [Related]
20. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. Klinger M; Eipeldauer S; Hacker S; Herberger B; Tamandl D; Dorfmeister M; Koelblinger C; Gruenberger B; Gruenberger T Eur J Surg Oncol; 2009 May; 35(5):515-20. PubMed ID: 19200687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]